Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Change in Inventory (2016 - 2025)

Nephros (NEPH) has 16 years of Change in Inventory data on record, last reported at $516000.0 in Q3 2025.

  • For Q3 2025, Change in Inventory rose 56.36% year-over-year to $516000.0; the TTM value through Sep 2025 reached -$257000.0, down 120.83%, while the annual FY2024 figure was $407000.0, 205.17% up from the prior year.
  • Change in Inventory reached $516000.0 in Q3 2025 per NEPH's latest filing, up from $318000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $516000.0 in Q3 2025 and bottomed at -$714000.0 in Q1 2023.
  • Average Change in Inventory over 5 years is -$45368.4, with a median of $44000.0 recorded in 2022.
  • Peak YoY movement for Change in Inventory: soared 463.08% in 2021, then plummeted 965.67% in 2023.
  • A 5-year view of Change in Inventory shows it stood at $236000.0 in 2021, then plummeted by 242.37% to -$336000.0 in 2022, then soared by 216.37% to $391000.0 in 2023, then plummeted by 211.51% to -$436000.0 in 2024, then soared by 218.35% to $516000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Inventory were $516000.0 in Q3 2025, $318000.0 in Q2 2025, and -$655000.0 in Q1 2025.